Tenax Therapeutics CEO Anthony DiTonno's 2021 pay jumps 44% to $1.1M
Tenax Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Tenax Therapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, five executives at Tenax Therapeutics received on average a compensation package of $749K, a 13% increase compared to previous year.
Anthony A. DiTonno, Chief Executive Officer, received $1.1M in total, which increased by 44% compared to 2020.
Michael B. Jebsen, Chief Financial Officer, received a compensation package of $980K, which increased by 64% compared to previous year. 41% of the compensation package, or $403K, was in other compensation.
Christopher T. Giordano, Chief Executive Officer, earned $861K in 2021.
Stuart Rich, Chief Medical Officer, received $818K in 2021.
Eliot M. Lurier, Chief Financial Officer, earned $26K in 2021.